Clinical Cancer Research Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salvesen, H. B.
Right arrow Articles by Das, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salvesen, H. B.
Right arrow Articles by Das, S.
Clinical Cancer Research Vol. 6, 3607-3613, September 2000
© 2000 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Methylation of hMLH1 in a Population-based Series of Endometrial Carcinomas1

Helga B. Salvesen2, Nicola MacDonald, Andy Ryan, Ole Erik Iversen, Ian J. Jacobs, Lars A. Akslen and Soma Das

Department of Pathology, The Gade Institute [H. B. S., L. A. A.] and Department of Gynecology and Obstetrics, Haukeland University Hospital [H. B. S., O. E. I.], N-5021 Bergen, Norway; Gynaecology Cancer Research Unit, Department of Gynaecological Oncology, St. Bartholomew’s Hospital and The Royal London Hospital School of Medicine and Dentistry, London EC1A 7BE, United Kingdom [N. M., A. R., I. J. J.]; and Department of Human Genetics, The University of Chicago, Chicago, Illinois 60637 [H. B. S., S. D.]

Microsatellite instability (MSI) is a characteristic feature of hereditary nonpolyposis colorectal cancer and is also observed in sporadic colorectal and endometrial cancers. Alterations in the mismatch repair genes hMLH1 and hMSH2 are important for the development of MSI. It has recently been demonstrated that hypermethylation of the hMLH1 promoter region is associated with MSI and appears to be a common mechanism for gene inactivation. For endometrial carcinoma, however, previous studies have been relatively small and have not been population based. We therefore wanted to assess the frequency and prognostic significance of hypermethylation of the hMLH1 and hMSH2 genes in conjunction with hMLH1 protein expression in a prospective and population-based series of endometrial carcinoma patients with known MSI status and complete follow-up. A total of 138 patients were studied, and methylation of hMLH1 was found in 23% of tumors with conclusive results, whereas methylation of hMSH2 was seen in only 1% of tumors. Methylation of hMLH1 was significantly correlated with MSI (P < 0.001). Loss of nuclear staining of hMLH1 protein was seen in 14% of the cases and was significantly correlated with hMLH1 methylation and MSI (P < 0.001). Normal expression of hMLH1 was seen in all of the unmethylated tumors (100%). Of the 14 MSI-positive tumors that were also methylated, all but 1 (93%) showed a loss of nuclear expression of hMLH1. None of the tumors with loss of hMLH1 expression or hMLH1 methylation were aneuploid (P for both <= 0.05), and loss of hMLH1 expression and hMLH1 methylation was significantly correlated with lack of p53 overexpression (P for both <= 0.05). Nuclear hMLH1 staining and hMLH1 methylation did not significantly influence survival. In conclusion, hMLH1 methylation was common and was significantly correlated with loss of hMLH1 protein expression, MSI, diploid tumors, and lack of p53 overexpression. In contrast, hMSH2 methylation was infrequent in this prospective and population-based series of endometrial carcinomas.




This article has been cited by other articles:


Home page
Ann OncolHome page
S. Demokan, Y. Suoglu, D. Demir, M. Gozeler, and N. Dalay
Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer
Ann. Onc., June 1, 2006; 17(6): 995 - 999.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. T. Soliman, R. R. Broaddus, K. M. Schmeler, M. S. Daniels, D. Gonzalez, B. M. Slomovitz, D. M. Gershenson, and K. H. Lu
Women With Synchronous Primary Cancers of the Endometrium and Ovary: Do They Have Lynch Syndrome?
J. Clin. Oncol., December 20, 2005; 23(36): 9344 - 9350.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Iwata, T. Fujita, N. Hirao, Y. Matsuzaki, T. Okada, H. Mochimaru, N. Susumu, E. Matsumoto, K. Sugano, N. Yamashita, et al.
Frequent Immune Responses to a Cancer/Testis Antigen, CAGE, in Patients with Microsatellite instability-Positive Endometrial Cancer
Clin. Cancer Res., May 15, 2005; 11(10): 3949 - 3957.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. Yan, A. B. Desai, J. W. Jacobberger, R. M. Sramkoski, T. Loh, and T. J. Kinsella
CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses
Mol. Cancer Ther., September 1, 2004; 3(9): 1147 - 1157.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Yan, S. E. Berry, A. B. Desai, and T. J. Kinsella
DNA Mismatch Repair (MMR) Mediates 6-Thioguanine Genotoxicity by Introducing Single-strand Breaks to Signal a G2-M Arrest in MMR-proficient RKO Cells
Clin. Cancer Res., June 1, 2003; 9(6): 2327 - 2334.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Viswanathan, G. Sangiliyandi, S. S. Vinod, B. K. C. Mohanprasad, and G. Shanmugam
Genomic Instability and Tumor-specific Alterations in Oral Squamous Cell Carcinomas Assessed by Inter- (Simple Sequence Repeat) PCR
Clin. Cancer Res., March 1, 2003; 9(3): 1057 - 1062.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Wang, W. Douglas, M. Lia, W. Edelmann, R. Kucherlapati, K. Podsypanina, R. Parsons, and L. H. Ellenson
DNA Mismatch Repair Deficiency Accelerates Endometrial Tumorigenesis in Pten Heterozygous Mice
Am. J. Pathol., April 1, 2002; 160(4): 1481 - 1486.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. Stefansson, L. A. Akslen, N. MacDonald, A. Ryan, S. Das, I. J. Jacobs, and H. B. Salvesen
Loss of hMSH2 and hMSH6 Expression Is Frequent in Sporadic Endometrial Carcinomas with Microsatellite Instability: A Population-based Study
Clin. Cancer Res., January 1, 2002; 8(1): 138 - 143.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Yan, J. E. Schupp, H.-s. Hwang, M. W. Wagner, S. E. Berry, S. Strickfaden, M. L. Veigl, W. D. Sedwick, D. A. Boothman, and T. J. Kinsella
Loss of DNA Mismatch Repair Imparts Defective cdc2 Signaling and G2 Arrest Responses without Altering Survival after Ionizing Radiation
Cancer Res., November 1, 2001; 61(22): 8290 - 8297.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. S. Amin, M.-N. Nguyen, S. Oh, and R. D. Kolodner
exo1-Dependent Mutator Mutations: Model System for Studying Functional Interactions in Mismatch Repair
Mol. Cell. Biol., August 1, 2001; 21(15): 5142 - 5155.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.